Surveillance on prescribed cardiovascular drugs by generic names in Dhaka city of Bangladesh.

Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels and they include: coronary heart disease,cerebrovascular disease ,peripheral arterial disease,rheumatic heart disease,congenital heart disease,deep vein thrombosis and pulmonary embolism etc.CVDs are the number one cause of death globally: more people die annually from CVDs than from any other cause. An estimated 17.3 million people died from CVDs in 2008, representing 30% of all global deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease and 6.2 million were due to stroke.Low- and middle-income countries are disproportionally affected: over 80% of CVD deaths take place in low- and middle-income countries and occur almost equally in men and women. By 2030, almost 25 million people will die from CVDs, mainly from heart disease and stroke. These are projected to remain the single leading cause of death. Most cardiovascular diseases can be prevented by addressing risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity, raised blood pressure, diabetes and raised lipids.7.5 million deaths each year, or 13% of all deaths can be attributed to raised blood pressure. This includes 51% of deaths due to strokes and 45% of deaths due to coronary heart disease. Prescriptions of Cardiac specialist and general physician of various renowned hospitals & medical college of Bangladesh were screened. About 1000 prescriptions were selected from randomly viewed 1200 prescriptions of National Heart Foundation & Dhaka Medical College Hospital outdoor. Finally, 700 prescriptions were selected for survey with proper supporting of patient. All of them were completely cardiac disease content which was prescribed by 99% specialist and 1% general physician. This Survey was carried out at the outdoor of National Heart Foundation & Dhaka Medical College Hospital, Dhaka, Bangladesh from Jan'12 to August'12. Out of the total patients with a male, female ratio was 57.14: 42.86 respectively, all patients were over 30 years and approximately 64.285 % the patients were the demographically urban area whereas 35.714% patients came from rural area. The percentage of prescribed Betaadrenoceptor blocker, Organic nitrates, Anticoagulant, anti-platelet and thrombolytic drug, Calcium channel blocker, Diuretics, Renin-angiotensin system drugs, Lipid lowering drugs, Miscellaneous drugs were respectively 25.00%, 19.57%,22.00%,8.42%,10.42%,10.40% and 2.85% respectively. This data may be guidelines for optimizing rational use of cardiovascular drugs and also a new statistical approach for effective cardiovascular disease management in Bangladesh. [ABSTRACT FROM AUTHOR]